OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
Jamie Lim, Roy Augustinus, Jaap J. Plomp, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Jamie Lim, Roy Augustinus, Jaap J. Plomp, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 20
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 20
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
Aigli G. Vakrakou, Eleni Karachaliou, Elisabeth Chroni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Aigli G. Vakrakou, Eleni Karachaliou, Elisabeth Chroni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 765
Closed Access | Times Cited: 2
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 765
Closed Access | Times Cited: 2
ARGX-119, a therapeutic agonist antibody targeting MuSK
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
Jamie Lim, Stine Marie Jensen, Jaap J. Plomp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Jamie Lim, Stine Marie Jensen, Jaap J. Plomp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis
Guanlian Hu, Xue Zhao, Yiren Wang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 707-720
Open Access
Guanlian Hu, Xue Zhao, Yiren Wang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 707-720
Open Access
Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
Jamie Lim, Stine Marie Jensen, Jaap J. Plomp, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111684-111684
Open Access
Jamie Lim, Stine Marie Jensen, Jaap J. Plomp, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111684-111684
Open Access
